As well as a role in regulating key CSC-associated traits such as clonogencity, tumour-initiating capability and chemotherapy resistance, LARP1 is required to maintain CD133+ and Aldefluorbright putative CSC-like populations. This evidence concerns the gene PROM1 and neoplasm.